Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Clinical trial NCT00303550 · COMPLETED

Trial details

NCT number: NCT00303550
Sponsor: Arpida AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Skin Diseases, Bacterial

Start date: 2006-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.